New research published in Blood found that stem cell transplantation was the most cost-effective treatment option for adults living with sickle cell disease compared with gene therapy and standard of care.
Read more 🔗 https://ow.ly/eiQj50Z7aPU
#HemeSky #ConquerSCD Blood Journals Portfolio
